Kenjirou Minomi

This inventor holds 17 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in RNA Interference. Top assignee: Nitto-Denko Corporation. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenjirou Minomi. Retrieved from https://idiyas.com/inventor/kenjirou-minomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 46(Granted Patents)

Company Filing History:

17 out of 3,953

Nitto-Denko Corporation

patents

Years Active: 2017-2024

Loading Chart...

Areas of Expertise:

siRNA Structures

RNA Interference

Gene Modulation

Malignant Tumors

KRAS Mutation

Cell Proliferation

Cell Death Agents

GST-Pi Gene

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11926831 - SiRNA structures for high activity and reduced off target (2024-03-12),

2. RE49431 - RNA interference agents for GST-PI gene modulation (2023-02-27),

3. RE49229 - Methods and compositions for treating malignant tumors associated with KRAS mutation (2022-10-03),

4. 11390871 - SiRNA structures for high activity and reduced off target (2022-07-19),

5. 11352628 - Methods and compositions for treating malignant tumors associated with KRAS mutation (2022-06-07),

6. RE48887 - RNA interference compositions and methods for malignant tumors (2022-01-10),

7. 11045488 - RNA interference agents for GST-π gene modulation (2021-06-29),

8. 10792299 - Methods and compositions for treating malignant tumors associated with kras mutation (2020-10-06),

9. 10780107 - Agent for inducing cell death, agent for suppressing cell proliferation, and pharmaceutical composition used for treatment of disease resulting from abnormal cell proliferation (2020-09-22),

10. 10405749 - RNA agents for P21 gene modulation (2019-09-10),

11. 10358647 - siRNA structures for high activity and reduced off target (2019-07-23),

12. 10047111 - RNA interference agents for GST-PI gene modulation (2018-08-14),

13. 10047110 - RNA agents for GST-Pi gene modulation (2018-08-14),

14. 10023597 - RNA interference agents for p21 gene modulation (2018-07-17),

15. 9771582 - RNA interference compositions and methods for malignant tumors (2017-09-26),

Title: Kenjirou Minomi - Pioneering Inventor from Osaka, JP

Introduction: Kenjirou Minomi is a renowned inventor hailing from Osaka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kenjirou Minomi holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his continuous dedication to pushing the boundaries of scientific advancement.

Career Highlights: With a career spanning over two decades, Kenjirou Minomi has worked with leading research institutions and tech companies, playing a key role in developing cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Kenjirou Minomi has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and knowledge-sharing that has led to numerous successful projects.

Conclusion: Kenjirou Minomi's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.